Based on 2023 trends reported by Statista.com*, the global gender gap is not expected to close for another 131 years - around 30 percent longer than the World Economic Forum's 2020 outlook predicted – due to the COVID-19 pandemic’s impact on women and girls in education and the workforce, and compounded by multiple economic and geopolitical crises.
With women's participation in the workforce often first to be affected by economic crises, we take a look at why this happens and how we can address this challenge in the life sciences: the longer-term impacts of COVID-19 combined with the imminent cost of living crisis potentially impacting our female leaders and employees the hardest?
Join us at Oxford’s Natural History Museum for tipples with the T-Rex, prosecco with the plesiosaur and canapes with the cetaceans! Come along to be inspired by our fantastic speakers and grow your network at our biggest ever WIB.
* Moving Backwards on the Long Road to Gender Equality, Katharina Buchholz, 21 June 2023
Karen is Head of Project Delivery at tranScrip and brings 28 years of experience working with large and small pharmaceutical companies, biotechs and CROs.
Karen is a senior industry professional with 28 years of experience, including senior positions in clinical development. She has a wealth of experience in the leadership of cross functional clinical study and development teams and has a successful track record in the design, budgeting and execution of clinical programmes supporting several product approvals.
Prior to joining tranScrip, Karen worked for several pharma and biotech companies including Summit Therapeutics where she was VP, Clinical Operations, Data Management and Project Management. Before that she was VP, Clinical Development with Shield Therapeutics. She also spent several years at Biogen, where she was the clinical development lead for several products, taking two products from phase I to marketing approvals in Japan, US and EU and supporting post-marketing commitments and life cycle management.
At tranScrip, Karen leads the Project Delivery department including Clinical Operations, Project Management and Medical Writing.
Sarah joined Oxford Science Enterprises in January 2022. She has over 20 years of experience building the boards and senior leadership teams of innovative, fast growth companies.
Sarah focusses on developing OSE’s talent strategy across sectors to drive value creation in the portfolio. She advises our companies on all talent related issues, attracts high performing executive and non-executive leadership to our portfolio companies and expands OSE’s international network of entrepreneurs, executives and advisors. Sarah also spearheads OSE’s external communications and marketing activities.
Sarah began her career as a US Government economist and trade negotiator working closely with the computer and biopharmaceutical industries. After moving into executive search, where she led search and assessment projects for Life Sciences, PE/VC and technology teams at global and boutique firms, she joined the investment firm Abingworth, as Partner for Marketing and Talent.
Sarah holds a BA in International Relations from Pomona College, California, and an MA in Public Affairs from Princeton University.